Drug lag and key regulatory barriers in the emerging markets

There have been numerous investigations targeted at identifying whether a drug lag exists in the mature markets of the US, EU and Japan. This work focuses on the emerging markets because of the potential they hold for the future of the pharmaceutical industry as a consequence of rapid economic and p...

Full description

Bibliographic Details
Main Authors: Harriet Wileman, Arun Mishra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2010-01-01
Series:Perspectives in Clinical Research
Subjects:
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2010;volume=1;issue=2;spage=51;epage=56;aulast=Wileman